Business Wire

PETROBRAS INVESTOR ALERT: $3B Settlement Covers Only US Securities. Majority of International Investors and Losses Not Covered

Jaa

Stichting Petrobras Compensation Foundation (SPCF or Foundation).

On January 3, 2018, Petrobras announced that in connection with the losses investors suffered from the “Lava Jato” bribery scandal, it had agreed to a USD 2.95 Billion settlement with investors who purchased American Depository Shares (ADS) and bonds in the US. The US settlement is a commendable and positive development, but it only provides recoveries for claims by purchasers in the United States and by purchasers of Petrobras securities that are listed for trading in the United States. The US issued and traded securities represent a limited portion of Petrobras global securities and related investor losses. The majority of investor losses occurred from trading in the Petrobras securities including Preferred and Common shares traded on the Brazilian exchange in São Paulo, European-regulated exchanges and bonds issued by Petrobras Global Finance, which is headquartered in the Netherlands, not in Brazil. The underlying fraud and events are the exact same and Petrobras should treat its investors equally. Petrobras should therefore compensate its investors regardless of which exchange, or in which country, they purchased Petrobras shares or bonds.

In January 2017, SPCF, backed by a coalition of international investors and law firms, started legal action against Petrobras and filed a Writ of Summons in District Court in Rotterdam, seeking declaratory relief for global investors who purchased Petrobras securities in non-US markets or on non-US exchanges.

The litigation in the Netherlands covers the principal Petrobras equity securities that traded on the BOVESPA exchange in São Paulo and via linked markets such as Latibex on Bolsa De Madrid. The litigation in the Netherlands also covers the claims of bondholders whose losses are not included in the US litigation.

A case management hearing took place on August 23, 2017 at the District Court in Rotterdam. Parties are now litigating preliminary issues. The focus of the case is expected to shift to the merits in the Summer of 2018. Any judgment issued by the court in favor of the Foundation, or any earlier settlement with the Foundation relating to investments in international securities (non-US securities), would be enforceable at least throughout Europe.

The Dutch litigation is a result of significant investigations and planning and was formalized in February 2016 by SPCF supported by a coalition of international investors, law firms, litigation funders and investor interest groups, to litigate against Petrobras with the goal of reaching a global binding resolution. The Foundation board is composed of prominent independent legal and finance expert directors, including a former Justice Secretary for the Dutch government and the Foundation’s Chairman Mr. H. TH. (Dick) Bouma, a former Justice at the Court of Appeals in The Hague.

The Foundation has significant support from institutional investors from around the world, including investors in the US, UK, Brazil, Netherlands, France, Germany, Spain, Italy, Nordic countries, Japan and others. Individual institutional investor losses range in the millions, tens of millions and in some instances close to USD 100 million. Investors have signed Foundation support and contingency success fee funding agreements, supporting and demonstrating their desire to pursue restitution for the losses they unfairly and unexpectedly suffered as a result of the illegal acts of Petrobras.

Many of Petrobras’ activities are structured via various entities in the Netherlands (Rotterdam). Petrobras also raises debt capital from investors via its Dutch subsidiary, Petrobras Global Finance B.V. (PGF), headquartered in Rotterdam (not in Brazil). Petrobras has issued an unconditional guarantee towards the debenture holders for the fulfillment of PGF’s obligations. Providing additional nexus to the Netherlands, the Petrobras corruption scandal reached into Holland via a Dutch listed company, SBM Offshore, that allegedly bribed Petrobras executives and ultimately settled with Dutch regulators for USD 240 million, the largest anti-corruption settlement in Dutch corporate history. Petrobras continues significant operations in the Netherlands to this day. Ultimately, the Dutch Collective Settlement Act (WCAM) is a framework that would permit Petrobras to obtain global peace with damaged investors.

Jurjen Lemstra, Partner at Lemstra Van der Korst – the leading law firm representing the Petrobras investors in the Netherlands – commented “Petrobras investors seeking to prosecute claims in Brazil cannot expect an adequate and fair trial, amongst others because the Brazilian system is one with many conflicts of interest. With strong nexus for this case in the Netherlands, the Dutch court system is the optimal international legal environment for the litigation against Petrobras, amongst others because Dutch courts have historically ruled favorably for Foundations representing shareholders, such as SPCF, in large multinational securities fraud collective actions.”

In the past, Petrobras promoted that European investors could elevate their confidence in the Company and its compliance, when it became subject to European regulators, including the Spanish financial markets regulator CNMV, in connection with various arrangements, including its linked-market arrangement with European exchanges, such as Bolsa Madrid, to trade and freely transfer its securities (same securities Cusip/ISIN as traded in Brazil) in custody between Brazil and Europe.

Investors that are interested in joining the action can contact ISAF, the administrative support agent and funding organizer for SPCF at info@isafmanagement.com

Global Coalition Information

Foundation. Stichting Petrobras Compensation Foundation (SPCF) is a Netherlands-based foundation that acts on behalf of damaged Petrobras investors who purchased securities on markets outside of the United States. More information about the Foundation can be found at www.pbcompensation.com

Contingency Investor Funding. SPCF has appointed International Securities Associations & Foundations Management Company for Damaged Petrobras Investors (Bovespa) Ltd. (ISAF) to coordinate with investors. ISAF has organized the funding of all litigation costs so that investors can participate with no upfront cost. More information about ISAF can be found at www.isafmanagement.com

Law Firms. Lemstra Van der Korst N.V., a leading Dutch litigation and class action law firm (Netherlands), acts on behalf of the Foundation and is consulting with securities litigation firms, Motley Rice LLC (US), Lowey Dannenberg Cohen & Hart, P.C. (US), Withers LLP (UK) and certain Brazilian law firms.

Claims Analysis and Processing. Battea Class Action Services, LLC, an international leader in class and collective action damages evaluations securities claims filings, has been retained to collect client data and process and validate investor losses. More information about Battea can be found at www.battea.com

MEDIA CONTACT: Lemstra Van der Korst N.V. / Flip Wijers, f.wijers@lvdk.com / Martijn van Dam, m.vandam@lvdk.com / Jurjen Lemstra, j.lemstra@lvdk.com

More information can be found on: www.lvdk.com

Contact information

MEDIA:
Lemstra Van der Korst N.V.
Flip Wijers, +31 (20) 2050567
f.wijers@lvdk.com
or
Martijn van Dam, +31 (20) 2050567
m.vandam@lvdk.com
or
Jurjen Lemstra, +31 (20) 2050567
j.lemstra@lvdk.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Manchester United and True Religion Launch Denim Range19.10.2018 20:37Tiedote

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10Tiedote

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54Tiedote

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr

Tradeshift Announces Q3 2018 Results19.10.2018 14:00Tiedote

Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between

Schlumberger Announces Third-Quarter 2018 Results19.10.2018 14:00Tiedote

Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme